# Study of the Anti-tumoral Immune Response

> **NCT02854644** · NA · COMPLETED · sponsor: **Centre Hospitalier Universitaire de Besancon** · enrollment: 167 (actual)

## Conditions studied

- Breast Cancer
- Glioma

## Interventions

- **OTHER:** additional blood sample

## Key facts

- **NCT ID:** NCT02854644
- **Lead sponsor:** Centre Hospitalier Universitaire de Besancon
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01-27
- **Primary completion:** 2021-10-27
- **Final completion:** 2021-10-27
- **Target enrollment:** 167 (ACTUAL)
- **Last updated:** 2022-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02854644

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02854644, "Study of the Anti-tumoral Immune Response". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02854644. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*